A Randomized, Double-Blind, Placebo-Controlled Trial of Spironolactone on Diastolic Dysfunction in Diabetic Patients

被引：0
|
作者：
Morales, Helia
Espinoza, Francisco
Larrea, Ricardo
Gonzalez, Bernardita
Puga, Luz
Vukusich, Antonio
Marusic, Elisa T.
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2099-PO
引用
收藏
页码：A562 / A562
页数：1
相关论文
共 50 条
  • [1] SPIRONOLACTONE FOR HYPOKALIA IN CAPD PATIENTS, A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL
    Yongsiri, Somchai
    Thammakumpee, Jiranuch
    Prongnamchai, Suriya
    Tengpraettanakorn, Pechngam
    Tangjaturonrasme, Siriporn
    Dinchuthai, Pakaphan
    Chueansuwan, Rachaneeporn
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 63 (05) : A116 - A116
  • [2] Randomized, Double-Blind, Placebo-Controlled Trial of Spironolactone for Hypokalemia in Continuous Ambulatory Peritoneal Dialysis Patients
    Yongsiri, Somchai
    Thammakumpee, Jiranuch
    Prongnamchai, Suriya
    Tengpraettanakorn, Pechngam
    Chueansuwan, Rachaneeporn
    Tangjaturonrasme, Siriporn
    Dinchuthai, Pakaphan
    THERAPEUTIC APHERESIS AND DIALYSIS, 2015, 19 (01) : 81 - 86
  • [3] Addition of Spironolactone in Patients With Resistant Arterial Hypertension (ASPIRANT) A Randomized, Double-Blind, Placebo-Controlled Trial
    Vaclavik, Jan
    Sedlak, Richard
    Plachy, Martin
    Navratil, Karel
    Plasek, Jiri
    Jarkovsky, Jiri
    Vaclavik, Tomas
    Husar, Roman
    Kocianova, Eva
    Taborsky, Milos
    HYPERTENSION, 2011, 57 (06) : 1069 - U94
  • [4] Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial
    Vaclavik, J.
    Sedlak, R.
    Plachy, M.
    Navratil, K.
    Plasek, J.
    Jarkovsky, J.
    Vaclavik, T.
    Husar, R.
    Kocianova, E.
    Taborsky, M.
    EUROPEAN HEART JOURNAL, 2011, 32 : 500 - 501
  • [5] Double-blind randomized placebo-controlled trial of sibutramine
    Bray, GA
    Ryan, DH
    Gordon, D
    Heidingsfelder, S
    Cerise, F
    Wilson, K
    OBESITY RESEARCH, 1996, 4 (03): : 263 - 270
  • [6] A Double-Blind, Randomized, Placebo-Controlled Clinical Trial on Benfotiamine Treatment in Patients With Diabetic Nephropathy
    Alkhalaf, Alaa
    Klooster, Astrid
    van Oeveren, Willem
    Achenbach, Ulrike
    Kleefstra, Nanne
    Slingerland, Robbert J.
    Mijnhout, G. Sophie
    Bilo, Henk J. G.
    Gans, Reinold O. B.
    Navis, Gerjan J.
    Bakker, Stephan J. L.
    DIABETES CARE, 2010, 33 (07) : 1598 - 1601
  • [7] Applicability of Press Needles to a Double-blind Trial A Randomized, Double-blind, Placebo-controlled Trial
    Miyazaki, Shougo
    Hagihara, Akihito
    Kanda, Ryo
    Mukaino, Yoshito
    Nobutomo, Koichi
    CLINICAL JOURNAL OF PAIN, 2009, 25 (05): : 438 - 444
  • [8] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFECT OF ENALAPRIL IN PATIENTS WITH CLINICAL DIABETIC NEPHROPATHY
    BAUER, JH
    REAMS, GP
    HEWETT, J
    KLACHKO, D
    MESSINA, C
    KNAUS, V
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 20 (05) : 443 - 457
  • [9] Marfan Sartan: a randomized, double-blind, placebo-controlled trial
    Milleron, Olivier
    Arnoult, Florence
    Ropers, Jacques
    Aegerter, Philippe
    Detaint, Delphine
    Delorme, Gabriel
    Attias, David
    Tubach, Florence
    Dupuis-Girod, Sophie
    Plauchu, Henry
    Barthelet, Martine
    Sassolas, Francois
    Pangaud, Nicolas
    Naudion, Sophie
    Thomas-Chabaneix, Julie
    Dulac, Yves
    Edouard, Thomas
    Wolf, Jean-Eric
    Faivre, Laurence
    Odent, Sylvie
    Basquin, Adeline
    Habib, Gilbert
    Collignon, Patrick
    Boileau, Catherine
    Jondeau, Guillaume
    EUROPEAN HEART JOURNAL, 2015, 36 (32) : 2160 - U37
  • [10] A double-blind, randomized, placebo-controlled laser trial methodology
    Oussedik, E.
    Saleem, M. D.
    Patel, N. U.
    Feldman, S. R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : B11 - B11
12345